0.59
-0.0034(-0.57%)
Currency In USD
| Previous Close | 0.59 |
| Open | 0.6 |
| Day High | 0.62 |
| Day Low | 0.59 |
| 52-Week High | 4.28 |
| 52-Week Low | 0.25 |
| Volume | 3.52M |
| Average Volume | 10.07M |
| Market Cap | 40.31M |
| PE | -1.48 |
| EPS | -0.4 |
| Moving Average 50 Days | 0.54 |
| Moving Average 200 Days | 0.68 |
| Change | -0 |
If you invested $1000 in Reviva Pharmaceuticals Holdings, Inc. (RVPH) since IPO date, it would be worth $63.23 as of December 04, 2025 at a share price of $0.614. Whereas If you bought $1000 worth of Reviva Pharmaceuticals Holdings, Inc. (RVPH) shares 5 years ago, it would be worth $56.33 as of December 04, 2025 at a share price of $0.614.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025
GlobeNewswire Inc.
Nov 12, 2025 1:00 PM GMT
CUPERTINO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis
GlobeNewswire Inc.
Nov 10, 2025 1:00 PM GMT
- Patent covers brilaroxazine use for treating Pulmonary Fibrosis -Similar patents have also been granted in key markets around the world including the United States, China, and Japan -Brilaroxazine has a novel mechanism of action for treating the un
Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference
GlobeNewswire Inc.
Oct 29, 2025 12:00 PM GMT
CUPERTINO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of